Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2338284
Max Phase: Preclinical
Molecular Formula: C35H37ClN4O5
Molecular Weight: 629.16
Molecule Type: Small molecule
Associated Items:
ID: ALA2338284
Max Phase: Preclinical
Molecular Formula: C35H37ClN4O5
Molecular Weight: 629.16
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cc2c(cc1OC)[C@@H]1[C@@H]3Cc4cc(OC)c(OC)cc4[C@H](CNC(=O)/C=C/c4ccc(Cl)cc4)N3[C@@H](C#N)[C@H](C2)N1C
Standard InChI: InChI=1S/C35H37ClN4O5/c1-39-26-12-22-15-31(43-3)33(45-5)17-25(22)35(39)27-13-21-14-30(42-2)32(44-4)16-24(21)29(40(27)28(26)18-37)19-38-34(41)11-8-20-6-9-23(36)10-7-20/h6-11,14-17,26-29,35H,12-13,19H2,1-5H3,(H,38,41)/b11-8+/t26-,27-,28-,29-,35+/m0/s1
Standard InChI Key: JMOWHQHDPYMGSZ-QCIFZFOVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 629.16 | Molecular Weight (Monoisotopic): 628.2452 | AlogP: 4.98 | #Rotatable Bonds: 8 |
Polar Surface Area: 96.29 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 4.73 | CX LogP: 4.91 | CX LogD: 4.91 |
Aromatic Rings: 3 | Heavy Atoms: 45 | QED Weighted: 0.35 | Np Likeness Score: 0.45 |
1. Guo J, Dong W, Liu W, Yan Z, Wang N, Liu Z.. (2013) Synthesis and cytotoxicity of 3-aryl acrylic amide derivatives of the simplified saframycin-ecteinascidin skeleton prepared from L-dopa., 62 [PMID:23434640] [10.1016/j.ejmech.2013.01.033] |
Source(1):